FABP2 and psoriasis: Loss of intestinal integrity has been reported in psoriasis based on a 51Cr-labeled ethylenediaminetetraacetic acid (EDTA) absorption test [231] and more recently through increased levels of barrier-related proteins such as claudin-3 and intestinal fatty acid binding protein (I-FABP) in serum [232].